Ajay Bharadwaj and Family

The Bharadwaj family’s strategic approach relies on the belief that corporate veterans can reinvent themselves as late-stage entrepreneurs, building the invisible R&D engines for global biotech. 

The Anthem Biosciences story is fundamentally about brotherhood and second acts. After spending over two decades helping build Biocon into a behemoth, Ajay Bharadwaj and his brother Ravindra (along with co-founder Ganesh Sambasivam) made a bold, late-career pivot. In 2006, well into their 50s, the brothers risked their life savings to launch Anthem, aiming to capture the booming contract research and manufacturing (CRDMO) market. 

Operating with the quiet efficiency of a tight-knit family unit, the brothers built Anthem into an FDA-approved powerhouse that top-tier Western pharma companies rely on for drug discovery. Today, the family legacy is being formalized as Ajay’s son, Ishaan Bharadwaj, steps into a leadership role as Vice President. Infusing modern operational rigor into the founders' deep scientific expertise, the family is currently steering this once-bootstrapped venture toward one of the sector's most anticipated initial public offerings.